She received IL2 and Interferon phase III protocol with stable disease.
She underwent resection of an isolated thyroid met in [**2141-12-9**], and had radiofrequency ablation of renal masses in [**2142**], [**2143**], and [**2144**].
She was planned for high dose IL2, but developed pyelonephritis/urosepsis and was hospitalized from [**2146-12-14**], through [**2146-12-19**], for intravenous fluids and intravenous antibiotics.
She has recovered well and completed her last antibiotic dose this morning.
History of hemangioma, status post cerebellar resection times two.
ALLERGIES:  Levofloxacin causes a rash.
Levoxyl 50 mcg p.o.
Phenobarbital 64.8 mg p.o.
Fosamax 70 mg p.o.
She is moving all extremities well with strength 5/5.
Sodium 136, potassium 4.3, chloride 101, CO2 30, ALT 15, AST 18, LDH 138, CK 24, alkaline phosphatase 156, total bilirubin 0.2, albumin 3.7, calcium 9.3, phosphorus 3.6, magnesium 1.9, uric acid 6.6.
Side effects initially included chills improved with Demerol and nausea improved with Ativan.
She developed an erythematous pruritic skin rash treated with topical lotion, as well as diarrhea improved with Lomotil.
She developed crackles on her pulmonary examination and was subjectively short of breath and 20 mg of intravenous Lasix was given.
She was started on Neo- Synephrine to help support her blood pressure.
Given need for maximum doses of Dopamine and Neo-Synephrine with systolic blood pressure remaining in the 80 range, she was transferred to the Medical Intensive Care Unit for further management and monitoring.
She was maintained on  Dopamine and Neo- Synephrine for blood pressure support.
During her initial hypotension on seven [**Hospital Ward Name 1826**], she was also noted to be hypoxic with an oxygen saturation in the mid 80s, markedly improved with oxygen by face mask.
She was maintained overnight in the Medical Intensive Care Unit with vasopressor support slowly weaned.
Her Dopamine was successfully weaned down and was discontinued early in the morning of [**2147-1-8**].
Laboratory abnormalities during this week included creatinine rise to 2.6, improved to 2.1 on the day of discharge; hyperbilirubinemia with a peak bilirubin of 3.8, improved to 1.7 on the day of discharge; metabolic acidosis with a bicarbonate low at 16, improved to 25 on the day of discharge; and an elevated alkaline phosphatase with peak alkaline phosphatase [**Location (un) 1131**] of 383 on the day of discharge.
She developed mild INR elevation on [**2147-1-7**], improved the next day to 1.1 after Vitamin K administration, and she had no evidence of myocarditis based on enzymes or echocardiogram.
She was mildly anemic with a hemoglobin of 12.1 and hematocrit of 35.1 without need for packed red blood cell transfusion.
She required intermittent electrolytes repletion throughout her hospitalization.
Her central line tip was sent for culture upon discharge.
Nystatin 5 cc p.o.
Keflex 500 mg p.o.
Ranitidine 150 mg p.o.
Compazine 10 mg p.o.
Ativan 1 mg p.o.
Benadryl 25 to 50 mg p.o.
Tylenol p.r.n.
Lasix 20 mg p.o.
</DISCHARGE DIAGNOSIS> Metastatic renal cell carcinoma, status post high dose IL2 therapy complicated by hypotension and hypoxia.
